Today, the CAFC issued a brief ruling in Telit Cinterion Deutschland GmbH v. 3G Licensing S.A., largely affirming a final ...

It is well established that “a petitioner in an inter partes review … is not permitted to assert a ground of unpatentability under 35 U.S.C. § ...

This week we speak with Scott McKeown, who is a shareholder at Wolf Greenfield and one of the leading U.S. PTAB practitioners ...

A federal appeals court has ruled against John Deere in a patent dispute with rival agricultural equipment maker AGCO Corp., ...

Femasys Inc., (Nasdaq: FEMY), a leading biomedical innovator addressing significant unmet needs in women's health worldwide, with a broad portfolio of disruptive ...

The new patent application covers a multi-functional process that integrates several off-the-shelf devices, including("Aduro" ...

Novartis Pharmaceuticals Corporation v. Torrent Pharma Inc., No. 23-2218 (Fed. Cir. 2025) — On January 10, 2025, the Federal Circuit reversed ...

Amazon countersued last July, alleging a dozen patent infringements by Nokia regarding cloud-computing tech. In the UK, a ...

Can-Fite BioPharma has secured a US patent for Namodenoson, its lead drug candidate, for use as an anti-obesity treatment.

CellTrust today reaffirms the company received Ex Parte Reexamination Certificates from the U.S. Patent and Trademark Office ...